Sodium Ferrous Citrate and 5-Aminolevulinic Acid Exert a Therapeutic Effect on Endotoxin-Induced Uveitis in Rats

Int J Mol Sci. 2023 Aug 31;24(17):13525. doi: 10.3390/ijms241713525.

Abstract

The metabolism of 5-aminolevulinic acid (ALA) is more efficient when combined with sodium ferrous citrate (SFC). Our previous study revealed that oral administration of ALA, which has anti-inflammatory properties, and SFC (ALA/SFC) immediately before lipopolysaccharide (LPS) inoculation suppressed endotoxin-induced uveitis (EIU) in rats. However, the therapeutic effect of ALA/SFC post-administration remains unexplored. Hence, this study aimed to evaluate the therapeutic efficacy of ALA/SFC on EIU in rats, which were administered with a gastric gavage of ALA/SFC (100/157 mg/kg) or prednisolone (Pred, 10 mg/kg) after 4 h of LPS inoculation. The treatment groups showed ameliorated clinical scores, inflammatory cells, protein levels in the aqueous humor (AqH), and histopathologic evaluation 24 h after LPS inoculation. Furthermore, the treatment groups had reduced tumor necrosis factor-α, nitric oxide, prostaglandin E2, and interleukin-6 levels in the AqH. ALA/SFC demonstrated an anti-inflammatory effect equivalent to that demonstrated by Pred. These findings indicate that ALA/SFC exerts a therapeutic effect on EIU in rats, indicating its clinical usefulness in uveitis treatment.

Keywords: 5-aminolevulinic acid; endotoxin-induced uveitis; prednisolone; therapeutic effect.

MeSH terms

  • Aminolevulinic Acid* / pharmacology
  • Aminolevulinic Acid* / therapeutic use
  • Animals
  • Endotoxins / toxicity
  • Lipopolysaccharides / toxicity
  • Prednisone
  • Rats
  • Uveitis* / chemically induced
  • Uveitis* / drug therapy

Substances

  • Aminolevulinic Acid
  • Endotoxins
  • ferrous citrate
  • Lipopolysaccharides
  • Prednisone